Larimar Therapeutics News and Activities
Presence
Larimar Therapeutics develops medicines for rare diseases. Its main work is protein therapies and clinical development programs for patients with serious genetic conditions and the healthcare providers who support them.
Larimar Therapeutics products and services overview:
- Rare disease therapies
- Protein medicines
- Clinical development
- Genetic disease treatments
Revenue: ~$0 million
Employees: 55
Headquarters: Bala Cynwyd, United States (USA)
Larimar Therapeutics is one of the...
Larimar Therapeutics is a company listed under the stock ticker LRMR (US).
Executives
View the org chart displaying its 32 main executives
Most searched biographies at Larimar Therapeutics
- Carole Ben-Maimon, Director, President and Chief Executive Officer
- Jonathan Leff, Director
- Tom Hamilton, Director
Popular executive movements at Larimar Therapeutics
- Hannah Lynes, who was Quality Manager, is promoted to Senior Manager, Quality (posted on March 31 2026).
Create your alert
to follow the executive moves at Larimar Therapeutics.
Pharmaceuticals
Larimar Therapeutics has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).
Popular M&A news in Pharmaceuticals
- Laboratoire Servier has announced the acquisition of Edgewise Therapeutics (posted on June 4 2026).
- Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
- Hims & Hers has acquired Eucalyptus (posted on June 2 2026).
Popular contacts in Pharmaceuticals
News
Press releases by Larimar Therapeutics
- Larimar Therapeutics Announces Presentation at the Upcoming Gordon Research Conference on Neurobiology of Brain Disorders - Larimar Therapeutics, Inc.
- Larimar Therapeutics Announces Oral Presentation at the Upcoming Gordon Research Conference on Mitochondria and Chloroplasts - Larimar Therapeutics, Inc.
- Larimar Therapeutics Announces Upcoming Scientific Conference Presentations - Larimar Therapeutics, Inc.
- Press Releases - Larimar Therapeutics, Inc.
- Press Releases - Larimar Therapeutics, Inc.
- Press Releases - Larimar Therapeutics, Inc.
- Press Releases - Larimar Therapeutics, Inc.
- Larimar Therapeutics Announces Upcoming Poster Presentations at the 4th Pan American Parkinson’s Disease and Movement Disorders Congress - Larimar Therapeutics, Inc.
- Larimar Therapeutics Reports First Quarter 2022 Operating and Financial Results - Larimar Therapeutics, Inc.
- News – Larimar Therapeutics
- View more press releases Close
Social media about Larimar Therapeutics
- Larimar Therapeutics on Wikipedia, Google News & Yahoo Finance
- Larimar Therapeutics on LinkedIn, X (Twitter) & YouTube
